pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
cobinamide
Marfan Syndrome
Mesa Science Associates Inc
0
catalysts
Marketed
cocaine hydrochloride
Numbrino (cocaine hydrochloride)
Local Anesthetic Effect
Cody Laboratories Inc
0
catalysts
Preclinical
colesevelam
COLESEVELAM (colesevelam [INN])
Diarrhea
Viscera Labs Inc
0
catalysts
Marketed
← prev
page 167 of 231
next →
131
Pain
89
Neurology
1
colesevelam hydrochloride
Colesevelam Hydrochloride (colesevelam hydrochloride)
Heterozygous Familial Hypercholesterolemia (heFH)
Nivagen Pharmaceuticals Inc
0
catalysts
Marketed
colestipol hydrochloride
Colestipol Hydrochloride (colestipol hydrochloride)
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)
Carnegie Pharmaceuticals LLC
0
catalysts
Marketed
colistimethate sodium
Colistimethate Sodium (colistimethate sodium)
Lower Respiratory Tract Infections
Xellia Pharmaceuticals USA LLC
0
catalysts
Marketed
collagenase clostridium histolyticum
Xiaflex (collagenase clostridium histolyticum)
Peyronies Disease
Auxilium Pharmaceuticals LLC
0
catalysts
Phase 2
comekibart
comekibart [INN]
Atopic Dermatitis (Atopic Eczema)
Shanghai Mabgeek Biotechnology Co Ltd
0
catalysts
Phase 1
comtifator
Alzheimer's Disease
Bristol-Myers Squibb Co
0
catalysts
Marketed
concizumab
Alhemo (concizumab)
Hemophilia A (Factor VIII Deficiency)
Novo Nordisk Inc
0
catalysts
Marketed
conestat alfa
Ruconest (conestat alfa [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Pharming Healthcare, Inc.
0
catalysts
Marketed
conivaptan hydrochloride
Vaprisol (conivaptan hydrochloride)
Hyponatremia
$CPIX
CUMBERLAND PHARMACEUTICALS INC
0
catalysts
Marketed
conjugated estrogens
Conjugated Estrogens (conjugated estrogens)
Hypoestrogenism
Ingenus Pharmaceuticals LLC
0
catalysts
Phase 3
contezolid
Diabetic Foot Infection (DFI)
Bacterial 70S ribosome
MicuRx Pharmaceuticals Inc
0
catalysts
Phase 3
contezolid acefosamil
Diabetic Foot Infection (DFI)
Bacterial 70S ribosome
MicuRx Pharmaceuticals Inc
0
catalysts
Marketed
copanlisib hydrochloride
Aliqopa (copanlisib hydrochloride)
Follicular Lymphoma
Bayer HealthCare Pharmaceuticals Inc
0
catalysts
Phase 3
coramitug
Amyloid Cardiomyopathy
Novo Nordisk AS
0
catalysts
Phase 2
corticorelin
corticorelin [INN]
Peritumoral Brain Edema
Curatis AG
0
catalysts
Marketed
corticotropin
Acthar (corticotropin [INN])
Membranous Glomerulonephritis
Cerium Pharmaceuticals Inc
0
catalysts
Phase 3
crenolanib besylate
Refractory Acute Myeloid Leukemia
Arog Pharmaceuticals Inc
0
catalysts
Phase 3
cretostimogene grenadenorepvec
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$CGON
CG Oncology, Inc.
0
catalysts
Marketed
crinecerfont
Crenessity (crinecerfont)
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)
$NBIX
NEUROCRINE BIOSCIENCES INC
0
catalysts
Marketed
crisaborole
Eucrisa (crisaborole)
Atopic Dermatitis (Atopic Eczema)
$PFE
PFIZER INC
0
catalysts
Phase 1
crisdesalazine
crisdesalazine [INN]
Amyotrophic Lateral Sclerosis
GNT Pharma Co Ltd
0
catalysts
Marketed
crizanlizumab
Adakveo (crizanlizumab-tmca)
Sickle Cell Disease
$NVS
NOVARTIS AG
0
catalysts
Marketed
crizotinib
Xalkori (crizotinib)
Anaplastic Large Cell Lymphoma (ALCL)
EML4-ALK
NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)
$PFE
PFIZER INC
0
catalysts
Marketed
crofelemer DR
Mytesi (crofelemer)
Chemotherapy-Induced Diarrhea (CID)
Anoctamin-1
Cystic fibrosis transmembrane conductance regulator
Napo Pharmaceuticals Inc
0
catalysts
Marketed
crotamiton
Crotan (crotamiton [INN])
Pruritus
Marnel Pharmaceuticals LLC
0
catalysts
Phase 3
crovalimab
Piasky (crovalimab-akkz)
Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic…
Complement C5
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 1
curcumin
Sickle Cell Disease
Vascarta Inc
0
catalysts
